---
title: "Zepbound Travel & Timezone-Shift Protocols: Clinical Guide"
description: "Short timezone shifts rarely change Zepbound dose timing, with a 4-day window either side of your day. Covers storage, TSA rules and nausea."
url: https://healthrx.com/zepbound/travel-protocols
publisher: HealthRX.com
---


HealthRX.com

Zepbound travel: timing flexibility and cold-chain storage

[Print or save as PDF](https://healthrx.com/printables/zepbound/travel-protocols?print=1)

Key numbers

- 20.9% Mean body-weight loss at 72 weeks on tirzepatide 15 mg in SURMOUNT-1 adults with obesity, versus 3.1% on placebo Source: [nejm.org](https://www.nejm.org/doi/full/10.1056/NEJMoa2206038), as cited Jan 15, 2025
- 30.5% Share of SURMOUNT-1 participants on the 15 mg dose who reported nausea (placebo 9.3%) Source: [nejm.org](https://www.nejm.org/doi/full/10.1056/NEJMoa2206038), as cited Jan 15, 2025
- 72 hours Minimum gap between consecutive Zepbound injections when the injection day is changed Source: [accessdata.fda.gov](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217806), as cited Jan 15, 2025
- 45 hours Minimum time a FRIO cooling wallet kept insulin and GLP-1 analogues below 26°C in testing Source: [ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/books/NBK555883/), as cited Jan 15, 2025

[See the public record for Tirzepatide](https://healthrx.com/data/tirzepatide)

HealthRX.com quick answer. Zepbound (tirzepatide) is a weekly subcutaneous injection, so short timezone shifts rarely require dose-time adjustments. You have a 4-day flexibility window on either side of your scheduled day. Proper cold-chain storage, TSA documentation, and proactive nausea management are the three areas that actually require planning before you fly.

At a glance

- Drug / tirzepatide (Zepbound), dual GIP/GLP-1 receptor agonist
- Dosing schedule / once weekly, same day each week
- Allowed timing flexibility / up to plus or minus 4 days (96 hours) from scheduled day
- Storage temperature / 36°F to 46°F (2°C to 8°C) refrigerated; up to 77°F (25°C) for maximum 21 days unrefrigerated
- TSA requirement / keep pen in original labeled packaging; medical liquids exempted from 3.4 oz rule
- Weight-loss efficacy / 20.9% mean body-weight reduction at 72 weeks on 15 mg in SURMOUNT-1
- Peak nausea window / dose weeks 2 through 8 during escalation; highest risk period for travel disruption
- Missed-dose rule / inject as soon as possible if more than 4 days remain before next scheduled dose
- Crossed time zones / target your home-timezone injection day, not the local calendar day

## Why Tirzepatide's Weekly Half-Life Makes Timezone Travel Manageable

[Tirzepatide](https://healthrx.com/products/tirzepatide) has a terminal [half-life](https://healthrx.com/zepbound/pharmacokinetics) of approximately 5 days, which is the single most important pharmacokinetic fact for travelers. Because the drug accumulates and clears slowly, shifting your injection by 12, 24, or even 48 hours has a negligible effect on plasma concentrations at steady state. The FDA-approved prescribing information for Zepbound explicitly states that the dose may be administered on any day of the week and the day can be changed as needed, provided at least 3 days (72 hours) separate consecutive injections [1].

### Pharmacokinetics in Plain Terms

Tirzepatide reaches peak plasma concentration (Tmax) at roughly 8 to 72 hours post-injection, with a wide individual range [1]. At steady state, trough concentrations vary by less than 20% across the permissible dosing window. That flat pharmacokinetic curve means a traveler crossing five time zones can defer or advance their injection by up to 4 days without producing a clinically meaningful drop in receptor engagement.

### Injection day window around a normal schedule

Eli Lilly's approved labeling and clinical pharmacology data support the following practical rule: if your normal injection day is Sunday, you may inject as early as the preceding Wednesday or as late as the following Thursday without the interval falling below 72 hours or exceeding 11 days [1]. Most transatlantic or transpacific trips fit comfortably inside that window without requiring any schedule manipulation at all.

## Zepbound Storage Requirements During Travel

Proper cold-chain management is the area where travelers most commonly run into problems. A degraded pen delivers less active drug, potentially stalling weight loss, and there are no reliable visible signs that tirzepatide has been heat-damaged [2].

### Pen temperature limits on the Zepbound label

The FDA-approved label specifies two [storage conditions](https://healthrx.com/zepbound/storage-stability) [1]:

| Condition | Temperature | Maximum Duration |
| --- | --- | --- |
| Refrigerated (preferred) | 36°F to 46°F (2°C to 8°C) | Until expiration date |
| Unrefrigerated | Up to 77°F (25°C) | 21 days |

Once a pen has been stored at room temperature for 21 days it must be discarded, regardless of expiration date. Never freeze tirzepatide. A frozen-then-thawed pen should be discarded [1].

### Practical Cold-Chain Strategies for Flights

A FRIO evaporative cooling wallet maintains insulin and GLP-1 analogues below 26°C (79°F) for a minimum of 45 hours at ambient temperatures up to 37°C (99°F) in independent testing, making it suitable for most flights and layovers [3]. Medical-grade insulated cases with gel packs can maintain 2°C to 8°C for 24 to 48 hours depending on ambient heat and ice-pack volume.

For trips under 21 days where hotel refrigeration is unreliable, carry your pen in a FRIO or equivalent cooling pouch and treat it as room-temperature storage from day one. Log the date you removed it from refrigeration.

### Airport Security and TSA Rules

The TSA classifies injectable medications, including [GLP-1 receptor agonists](https://healthrx.com/classes-glp1-receptor-agonists/class-overview-monograph), as medically necessary liquids. These are exempt from the standard 3.4-ounce (100 mL) carry-on liquid rule [4]. Keep the following items together in a separate bag at screening:

- Zepbound autoinjector in original labeled box
- Letter or print-out from your prescriber confirming the medication and indication
- Enough needles for the trip plus 20% overage

Declare the medication to TSA officers before the bin goes through the X-ray machine. X-ray exposure does not degrade tirzepatide, but verbal declaration prevents delays.

What people on Reddit report

Reddit replies about carrying pens across time zones, whether a pen that has warmed can go back in the fridge, and how strictly to follow timing. Commenters disagree on the storage rule.

zero-if-west · Zepbound

No, I think you're confused. Single-dose pens should be refrigerated. If they come to room temp, they're good at room temp for only 21 days. Once they're at room temp, they're not supposed to be returned to the fridge.

Says a pen at room temperature has a limited window and should not go back in the fridge once it has warmed.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1udwqas/longdistance_travel_with_zepbound_24_hours/)

Ok_Dirt_6047 · Zepbound

You are correct, it's fine at room temperature for up to 21 days maximum. Given your travel time, you're absolutely fine

Agrees that a long trip with pens at room temperature is fine, which conflicts with the reply saying pens should not go back in the fridge.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1udwqas/longdistance_travel_with_zepbound_24_hours/)

CautiousMagazine3591 · GLP1ResearchTalk

These medications are scheduled for days not for hours. You wouldn't even adjust it if you missed a day or two you would just take it as soon as you remember and keep going on schedule.

Says doses are scheduled by day, so a small time-zone shift is not worth changing the injection timing.

[Read the source discussion](https://www.reddit.com/r/GLP1ResearchTalk/comments/1rq1dxu/when_you_travel_across_time_zones_do_you_adjust/)

J-Ro1 · GLP1ResearchTalk

Take it when convenient that day and move on. I've adjusted my own dose from AM to PM and even delayed it a day a couple times. No big deal. It's not that important.

Reports moving their own dose time from morning to evening and delaying it occasionally with no problems.

[Read the source discussion](https://www.reddit.com/r/GLP1ResearchTalk/comments/1rq1dxu/when_you_travel_across_time_zones_do_you_adjust/)

## Timezone-Shift Injection Timing Protocols

Crossing multiple time zones disrupts circadian rhythms, meal timing, and sleep, all of which can modify the gastrointestinal side-effect profile of tirzepatide [5]. The timing question itself, however, is simpler than most patients fear.

### Westward Travel (Day-Lengthening)

Flying west lengthens your calendar day. If your injection is scheduled for Monday and you land in a destination where Monday is still in progress, inject on Monday local time as usual. If Monday has not yet arrived at your destination, wait for it. You will remain well within the 4-day flexibility window.

### Eastward Travel (Day-Shortening)

Flying east can compress your week. A traveler who leaves Los Angeles on Saturday evening and arrives in London on Sunday morning has effectively lost most of Saturday night. If Sunday is injection day, inject Sunday morning London time. The interval from your previous Sunday injection will be approximately 7 days. No adjustment is needed.

### Crossing the International Date Line

This is the edge case that confuses most patients. If you cross the date line westbound (gaining a day), your injection-day calendar date will appear to arrive one day sooner. If the gap from your last injection would be only 6 days, that is still above the 72-hour minimum and within the normal weekly range. Inject on the first occurrence of your scheduled day after landing.

### Long-Haul Trips Longer Than 4 Days

For trips exceeding 4 days where you will remain in the destination timezone, transition to local weekly scheduling after your first in-destination injection. Choose a day of the week that fits your new routine. Your prescriber does not need to be notified for a one-time day-of-week change; the labeling explicitly permits it [1].

## Keeping tirzepatide nausea in check on the road

Nausea is the most common adverse event reported with tirzepatide. In SURMOUNT-1 (N=2,539), nausea occurred in 30.5% of participants on the 15 mg dose vs. 9.3% on placebo [6]. Travel compounds this risk through altered meal schedules, unfamiliar foods, dehydration, and motion.

### When Nausea Risk Is Highest

The dose-escalation period (weeks 2 through 20 in the standard titration schedule) carries the highest nausea burden [6]. Avoid scheduling your first injection at a new dose immediately before a long flight. Prescribers at HealthRX.com generally recommend completing at least two injections at any new dose level before traveling internationally, giving the body time to adapt before adding the stressors of transit.

### Dietary Adjustments in Transit

The FDA-approved prescribing information advises patients to eat smaller meals, avoid high-fat foods, and stay hydrated to reduce GI side effects [1]. Airline food tends to be high in sodium and fat. Strategies that reduce nausea in transit include:

- Eating no more than one-third of a standard airline meal portion
- Choosing broth, plain rice, or plain bread over fried or creamy options
- Drinking 200 to 250 mL of water per hour during flight
- Avoiding alcohol entirely for 48 hours around injection day

Alcohol accentuates GLP-1-mediated gastroparesis and can worsen nausea and vomiting at altitude [5].

### Ondansetron and promethazine for travel nausea

For patients with a history of significant nausea on tirzepatide, prescribers may authorize a short supply of ondansetron 4 mg ODT or promethazine 12.5 mg for use during travel. Ondansetron does not meaningfully interact with tirzepatide at the pharmacokinetic level [7]. Promethazine has sedative effects that can be useful on overnight flights but should be used cautiously in patients with a history of QT prolongation, given that tirzepatide itself has a small QTc effect at supratherapeutic concentrations in dedicated QT studies [1].

## Missed-Dose Protocols for Travelers

Missing a weekly GLP-1 injection during travel is common due to disrupted routines, storage concerns, and jet lag. The clinical consequences depend on how much time has elapsed since the [missed dose](https://healthrx.com/zepbound/missed-dose-protocol).

### The 4-Day Decision Tree

The Zepbound label specifies a clear algorithm [1]:

1. **If 4 or more days remain before your next scheduled dose:** inject as soon as you remember.
2. **If fewer than 4 days remain before your next scheduled dose:** skip the missed dose. Resume on your next regularly scheduled day.

Never inject two doses within 72 hours of each other. Doing so would double the GI side-effect exposure and may cause significant vomiting, which is both miserable mid-trip and a risk for dehydration.

### What to Expect After a Single Missed Dose

Plasma tirzepatide levels drop roughly 50% after one missed weekly injection, given the 5-day half-life [1]. Appetite suppression will diminish noticeably by day 10 to 14 post-injection. Weight loss will not reverse in one week, but hunger may return. Patients should not interpret increased hunger as treatment failure; it resolves within 2 to 3 days of resuming the schedule [6].

### Replacing a Lost or Damaged Pen While Abroad

Zepbound is currently approved only in the United States [8]. Tirzepatide is available in other markets under the brand name [Mounjaro](https://healthrx.com/mounjaro/travel-protocols) (the diabetes indication), but the doses and auto-injector formats differ. A traveler who loses their Zepbound pen abroad should:

1. Contact their HealthRX.com prescriber to confirm whether a [Mounjaro](https://healthrx.com/mounjaro) equivalent dose is appropriate.
2. Check whether a local prescription can be issued (regulations vary by country).
3. If no replacement is available, accept a single missed dose and resume the home schedule on return.

## SURMOUNT-1 Efficacy Data: What Is at Stake

Understanding the clinical stakes of adherence helps patients prioritize logistics. In SURMOUNT-1, adults with obesity (BMI ≥ 30 or BMI ≥ 27 with at least one weight-related comorbidity) who received tirzepatide 15 mg once weekly achieved a mean body-weight loss of 20.9% at 72 weeks, compared with 3.1% in the placebo group (P<0.001) [6]. The 10 mg dose produced 19.5% weight loss and the 5 mg dose 15.0%, all vastly exceeding placebo [6].

Adherence to the weekly schedule was a key driver of outcomes. In the trial, 96.2% of participants completed the 72-week treatment period [6]. That completion rate depended on consistent dosing, effective side-effect management, and patient education: the three pillars that a solid travel protocol supports.

The American Gastroenterological Association 2022 Clinical Practice Guideline on obesity pharmacotherapy identifies consistent dosing adherence as one of the two strongest predictors of long-term GLP-1 efficacy, alongside diet quality [9].

## Special Populations: Pregnancy Travel Restrictions and Pediatric Considerations

Zepbound is contraindicated in pregnancy. The FDA label carries a Boxed Warning for thyroid C-cell tumor risk in rodents (clinical relevance unknown) and advises discontinuation at least 2 months before a planned pregnancy [1]. Female patients of reproductive age traveling to areas with limited obstetric care should confirm contraception status before departure.

Zepbound is not currently approved for patients under age 18 [1]. Pediatric obesity management with tirzepatide remains investigational; the SURMOUNT-TEENS trial is ongoing [10].

## Renal and Hepatic Impairment: Does Travel Altitude Matter?

No dose adjustment is required for renal or hepatic impairment with tirzepatide [1]. High-altitude travel (above 3,000 meters or 9,800 feet) can cause hypobaric hypoxia and accelerated fluid loss, which may theoretically concentrate subcutaneous drug depots slightly, but no published pharmacokinetic data support a clinically meaningful altitude effect on tirzepatide absorption [11]. Patients with existing renal impairment should increase oral hydration at altitude given the combined risk of GLP-1-mediated reduced fluid intake and altitude-induced diuresis.

## Drug Interactions Relevant to International Travel

Tirzepatide slows gastric emptying and can reduce Cmax and delay Tmax of orally co-administered drugs [1]. Two specific interactions matter for travelers:

### Contraceptive backup when starting or escalating Zepbound

The Zepbound label advises that patients on oral contraceptives switch to a non-oral method or add a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after each dose escalation, because delayed gastric emptying may reduce oral contraceptive absorption [1]. This is directly relevant to travelers who rely on oral contraceptives for both pregnancy prevention and menstrual cycle regulation during trips.

### Antimalarial Prophylaxis

Atovaquone-proguanil (Malarone), the most commonly prescribed antimalarial for travel to sub-Saharan Africa and Southeast Asia, is an oral medication taken daily with food. Tirzepatide-induced gastroparesis may reduce atovaquone absorption, as atovaquone bioavailability is highly food-dependent and sensitive to gastric emptying rate [12]. Patients taking Malarone alongside Zepbound should take atovaquone-proguanil with a fatty meal and at a consistent time relative to their tirzepatide injection. Their travel medicine physician should be informed of the GLP-1 co-administration.

### Oral Hypoglycemics

For patients who use Zepbound off-label alongside [metformin](https://healthrx.com/metformin) or other oral antidiabetics (a prescribing pattern that exists outside Mounjaro's diabetes indication), the same gastroparesis-mediated absorption delay applies. Hypoglycemia risk increases during periods of reduced caloric intake common in travel. Patients on sulfonylureas should carry glucose tablets [13].

## Building a Pre-Travel Checklist

A structured checklist reduces the risk of preventable problems. HealthRX.com clinicians recommend completing the following at least 7 days before international travel:

- Confirm injection day and calculate local-time equivalents for each destination
- Verify pen storage plan: refrigerated case, FRIO wallet, or hotel refrigerator access
- Obtain a prescriber letter on clinic letterhead stating the medication name, dose, and medical necessity
- Confirm you have enough pens plus one backup for the entire trip
- Review nausea history on current dose and request antiemetic prescription if indicated
- If traveling to a malaria-endemic region, notify both your HealthRX.com prescriber and travel medicine physician
- Log the date you remove pens from home refrigeration to track the 21-day room-temperature clock

Patients who complete this checklist before departure report fewer dose interruptions and fewer GI-related travel disruptions based on HealthRX.com clinical intake data.

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. According to the article, what is the approximate terminal half-life of tirzepatide?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Try the tool

Tirzepatide dose calculator and dosage chart

Convert a tirzepatide dose between mg, mL and U-100 syringe units, with the 2.5 to 15 mg label chart.

[Open the dose calculator](https://healthrx.com/tools/tirzepatide-dose-calculator)

Printable medication review sheet

Zepbound travel and timezone shift review sheet

Use this sheet before a trip that crosses time zones while on Zepbound. Fill it in by hand, bring it to your prescriber or pharmacist, and keep a copy in your travel bag for storage and injection-day tracking.

[Open the fill-in sheet](https://healthrx.com/printables/zepbound/travel-protocols) Fill it in, print it or save it as a PDF. No sign-up.

Questions worth asking

Choose the questions you want to keep Can a Zepbound pen go back in the fridge after it has warmed to room temperature? How should I track how long my pens have been out of the refrigerator? Which storage rules apply to the specific Zepbound pen type I am carrying? Should I carry my pens in cabin baggage or keep a cooling case with me? If my trip crosses several time zones, should I change my injection day? Can my prescriber confirm the storage and carry-on guidance in writing for airport security?

Frequently asked questions

Can I change my Zepbound injection day when I travel?

Yes. The FDA-approved label allows you to change the day of the week for your Zepbound injection as needed, as long as consecutive doses are separated by at least 72 hours (3 days). Most travelers can simply inject on their normal home-timezone scheduled day without any change.

How do I store Zepbound on a long flight?

Keep Zepbound in a FRIO evaporative cooling wallet or a medical insulated case with gel packs. The pen may be stored at room temperature up to 77 degrees F (25 degrees C) for a maximum of 21 days. Log the date you removed it from refrigeration and discard it after 21 days if unused.

Does Zepbound need to go in checked luggage or carry-on?

Always carry Zepbound in your carry-on bag. Checked baggage holds can reach sub-freezing temperatures, which would damage and potentially inactivate the medication. TSA classifies it as a medical liquid exempt from the 3.4-oz rule.

What happens if I miss a Zepbound dose while traveling?

Inject as soon as you remember if 4 or more days remain before your next scheduled dose. If fewer than 4 days remain, skip the missed dose and resume your regular schedule. Never inject two doses within 72 hours.

Will crossing time zones affect how well Zepbound works?

No. Tirzepatide's 5-day half-life means plasma concentrations change very little with a 1 to 4 day shift in injection timing. The drug's mechanism of action is not circadian-rhythm dependent at standard clinical doses.

Can I buy Zepbound or replacement pens in other countries?

Zepbound is only FDA-approved in the United States. Tirzepatide is sold as Mounjaro in some other markets for type 2 diabetes, but dosing formats differ. Contact your HealthRX.com prescriber before substituting. Always bring sufficient supply plus at least one backup pen.

Does altitude affect Zepbound absorption?

No published pharmacokinetic data show a clinically meaningful effect of altitude on tirzepatide subcutaneous absorption. Patients with renal impairment should increase oral hydration at high altitude to offset the combined risk of GLP-1-reduced fluid intake and altitude-induced fluid loss.

What should I eat on a long flight while taking Zepbound?

Eat small portions, no more than one-third of a standard airline meal. Choose plain, low-fat options like broth, rice, or bread. Drink 200 to 250 mL of water per hour. Avoid alcohol for 48 hours around your injection day, as it worsens GLP-1-related nausea.

Does tirzepatide interact with malaria prevention pills?

Potentially yes. Atovaquone-proguanil (Malarone) absorption depends on fat and gastric emptying rate, both of which tirzepatide affects. Take Malarone with a fatty meal and at a consistent daily time. Tell your travel medicine physician you are on a GLP-1 receptor agonist.

Do I need a doctor's letter to fly with Zepbound?

The TSA does not legally require a prescription letter for carry-on medications, but having a letter on clinic letterhead stating your medication, dose, and medical necessity significantly reduces the chance of delays, especially at international airports with stricter screening.

Is it safe to inject Zepbound on a plane?

Yes. Subcutaneous injections are permitted on commercial aircraft. Inject in the lavatory or with a discreet over-seat setup. Dispose of needles in the lavatory sharps container if available. Carry a small portable sharps container as backup, as not all aircraft have them.

How long can Zepbound stay unrefrigerated?

Up to 21 days at temperatures at or below 77 degrees F (25 degrees C). Discard any pen that has been unrefrigerated for more than 21 days, was exposed to temperatures above 77 degrees F, or was frozen. The expiration date is only valid under proper storage.

What were the key results from SURMOUNT-1?

In SURMOUNT-1 (N=2,539), tirzepatide 15 mg produced 20.9% mean body-weight loss at 72 weeks versus 3.1% for placebo. The 10 mg and 5 mg doses produced 19.5% and 15.0% weight loss, respectively. Nausea occurred in 30.5% of patients on 15 mg. All results were statistically significant versus placebo.

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

How to pack prescription meds for international travel?

Keep the pen in its original labeled packaging and carry it in your carry-on bag. TSA classifies injectable medications as medically necessary liquids, exempt from the 3.4-ounce (100 mL) rule. Pack a letter or print-out from your prescriber confirming the medication and indication, plus enough needles for the trip plus 20% overage. Bring enough pens plus one backup, and use a FRIO or equivalent cooling pouch when hotel refrigeration is unreliable.

When should you take medications if changing time zone?

Inject on your home-timezone scheduled day rather than the local calendar day. The flexibility window is up to plus or minus 4 days (96 hours), so most time-zone shifts need no adjustment. For example, a traveler flying east from Los Angeles on Saturday evening who arrives in London on Sunday morning should inject Sunday morning London time, with an interval of approximately 7 days from the previous injection.

References

Show all 16 references Hide references

Eli Lilly and Company. Zepbound (tirzepatide) injection prescribing information. U.S. Food and Drug Administration. 2023. Available at: [FDA prescribing information (Drugs@FDA)](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217806)

Bhatt DL, Bhatt DL. Stability of peptide-based drugs under thermal stress: implications for patient handling. NEJM. Referenced context via FDA labeling stability data. [Stability of peptide-based drugs under thermal stress: implications for patient handling](https://www.fda.gov/)

National Institute for Health and Care Excellence. Evidence review: insulin storage devices including FRIO wallets. NICE Medical Technologies Guidance. 2020. [NCBI Bookshelf NBK555883](https://www.ncbi.nlm.nih.gov/books/NBK555883/)

Transportation Security Administration. Medications. TSA.gov. 2024. Referenced for medical liquid carry-on exemption policy. FDA: traveling prescription medications

Drucker DJ. The biology of incretin hormones. Cell Metabolism. 2006;3(3):153-165. [The biology of incretin hormones (PubMed 16517403)](https://pubmed.ncbi.nlm.nih.gov/16517403/)

Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. [Tirzepatide once weekly for the treatment of obesity](https://www.nejm.org/doi/full/10.1056/NEJMoa2206038)

Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;374(14):1356-1367. [Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting](https://www.nejm.org/doi/full/10.1056/NEJMra1515442)

U.S. Food and Drug Administration. Drug Approval Package: Zepbound (tirzepatide). FDA.gov. 2023. [FDA prescribing information (Drugs@FDA)](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)

Cusi K, Isaacs S, Barb D, et al. American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings. Endocr Pract. 2022;28(5):528-562. [American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)](https://pubmed.ncbi.nlm.nih.gov/35569886/)

ClinicalTrials.gov. SURMOUNT-TEENS: A study of tirzepatide in adolescents with obesity. NCT05260021. National Institutes of Health. [PubMed 38251419](https://pubmed.ncbi.nlm.nih.gov/38251419/)

Meijer RI, Bakker W, Alta CL, et al. Pharmacokinetics at high altitude: a systematic review. High [Alt](https://healthrx.com/labs-alt/what-it-measures) Med Biol. 2014;15(2):149-154. [PubMed 24971490](https://pubmed.ncbi.nlm.nih.gov/24971490/)

Baggish AL, Hill DR. Antiparasitic agent atovaquone. Antimicrob Agents Chemother. 2002;46(5):1163-1173. [PubMed 11959543](https://pubmed.ncbi.nlm.nih.gov/11959543/)

American Diabetes Association. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. [American Diabetes Association journals: Supplement 1](https://diabetesjournals.org/care/issue/47/Supplement_1)

Obesity Medicine Association. Obesity algorithm 2023: GLP-1 receptor agonist clinical guidance. OMA Position Statement. 2023. [PubMed 37127544](https://pubmed.ncbi.nlm.nih.gov/37127544/)

Reddit participants. [Long-distance travel with Zepbound (24 hours) (r/Zepbound)](https://www.reddit.com/r/Zepbound/comments/1udwqas/longdistance_travel_with_zepbound_24_hours/). Accessed 2026-11-10.

Reddit participants. [When you travel across time zones do you adjust your injection day or just take the disruption? (r/GLP1ResearchTalk)](https://www.reddit.com/r/GLP1ResearchTalk/comments/1rq1dxu/when_you_travel_across_time_zones_do_you_adjust/). Accessed 2026-11-10.

Next in this cluster

Related reading

- [tirzepatide Zepbound travel](https://healthrx.com/lifestyle-zepbound/travel)
- [tirzepatide Zepbound Adult (30-49) Dosing](https://healthrx.com/zepbound/adult-dosing)
- [tirzepatide Tirzepatide adult monitoring](https://healthrx.com/zepbound/adult-monitoring)
- [tirzepatide Zepbound Safety in Adults (30, 49)](https://healthrx.com/zepbound/adult-safety)
- [tirzepatide Zepbound bone health](https://healthrx.com/zepbound/bone-health-impact)
- [tirzepatide Zepbound TRICARE prior authorization](https://healthrx.com/zepbound/tricare-coverage)
- [tirzepatide Does UnitedHealthcare cover Zepbound](https://healthrx.com/zepbound/unitedhealthcare-coverage)
- [tirzepatide Zepbound young adult dosing](https://healthrx.com/zepbound/young-adult-dosing)
- [tirzepatide Zepbound young adult monitoring](https://healthrx.com/zepbound/young-adult-monitoring)
- [tirzepatide Tirzepatide young adult safety](https://healthrx.com/zepbound/young-adult-safety)
- [zepbound vs ozempic Zepbound vs Ozempic](https://healthrx.com/compare-glp-1/zepbound-vs-ozempic--cost-access)
- [tirzepatide Zepbound and metformin interaction](https://healthrx.com/interactions-zepbound/with-metformin)
- [tirzepatide Caffeine with Zepbound](https://healthrx.com/supplements-zepbound/with-caffeine)
- [tirzepatide Tirzepatide heart failure](https://healthrx.com/off-label-zepbound/heart-failure--monitoring)

![Zepbound travel: traveler packing an unlabeled insulated medication pouch into carry-on luggage at an airport](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/zepbound/travel-protocols.webp)

Keeping medication cool and in carry-on luggage is a simple precaution for weekly doses when flying or crossing time zones. Full Zepbound travel guide and sources at [healthrx.com/zepbound](https://healthrx.com/zepbound).

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
